TSHA - Taysha Gene Therapies  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TSHA is currently covered by 15 analysts with an average price target of $10.31. This is a potential upside of $7.69 (293.51%) from yesterday's end of day stock price of $2.62.

Taysha Gene Therapies 's activity chart (see below) currently has 32 price targets and 75 ratings on display. The stock rating distribution of TSHA is 95.65% BUY and 4.35% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.4% with an average time for these price targets to be met of 57.33 days.

Highest price target for TSHA is $7, Lowest price target is $4, average price target is $10.31.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 02-May-2024. First documented stock forecast 19-Oct-2020.

Currently out of the existing stock ratings of TSHA, 44 are a BUY (95.65%), 2 are a HOLD (4.35%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$4.38 (167.18%)

7

5 days ago

0/7 (0%)

$4.42 (171.32%)

Buy

7

$4.38 (167.18%)

7

7 days ago

1/7 (14.29%)

$4.57 (188.07%)

137

Buy

5

$2.38 (90.84%)

5

5 months 22 days ago

0/4 (0%)

$3.32 (197.62%)

Buy

7

$4.38 (167.18%)

8

5 months 22 days ago

0/4 (0%)

$5.32 (316.67%)

Buy

6

$3.38 (129.01%)

7

7 months 17 days ago

0/2 (0%)

$2.94 (96.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TSHA (Taysha Gene Therapies ) average time for price targets to be met?

On average it took 57.33 days on average for the stock forecasts to be realized with a an average price target met ratio 15.4

Which analyst has the current highest performing score on TSHA (Taysha Gene Therapies ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on TSHA (Taysha Gene Therapies )?

Salveen Richter works at GOLDMAN SACHS and has 8 price targets and 5 ratings on TSHA

Which analyst is the currently most bullish on TSHA (Taysha Gene Therapies )?

Yanan Zhu with highest potential upside - $7.38

Which analyst is the currently most reserved on TSHA (Taysha Gene Therapies )?

Eun Yang with lowest potential downside - -$1.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?